Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NER1006 versus Citrafleet for day-before bowel cleansing
2014-002186-30Phase 3Completed
- Sponsor
- Norgine
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial comparing NER1006 with Citrafleet (2 arms). Primary endpoint: Overall bowel cleansing success rate. Started Aug 2014; status: completed.
02
Drugs
polyethylene glycol plus ascorbatesodium picosulfate
Beyond the preview
Go deeper on 2014-002186-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002186-30.